Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-12-23 | New | $37,849,815 | $37,849,815 | Equity Only | 06b | SEC link |
| 2024-10-22 | Amended | $85,034,866 | $24,432,246 | Equity Only | 06b | SEC link |
| 2023-11-09 | Amended | $60,602,620 | $28,841,434 | Equity Only | 06b | SEC link |
| 2022-12-02 | New | $31,761,186 | $31,761,186 | Equity Only | 06b | SEC link |
| 2019-02-06 | New | $5,000,000 | $5,000,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Rahul Ballal | Director, Executive |
| Michael Baran | Director |
| Maina Bhaman | Director |
| Cassidy Blundell | Director |
| Stacey Brenner | Executive |
| Adam Cotton | Director |
| David De Graaf | Director |
| Meredith Fisher | Director |
| Brian Hubbard | Director |
| Andreas Jurgeit | Director |
| Anja Konig | Director |
| Allan Marchington | Director |
| Peter Parker | Director |
| Marie Claire Peakman | Director |
| Nandita Shangari | Director |
| Bharat Srinivasa | Director |
| Simon Sturge | Director |